跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia
M. H. Yang
, C. H. Ho
*
*
此作品的通信作者
臨床醫學研究所
研究成果
:
Article
›
同行評審
3
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Cladribine
100%
Hairy Cell Leukemia
100%
2-chlorodeoxyadenosine
100%
Purine Analogues
50%
Tartrate-resistant Acid Phosphatase
33%
Splenomegaly
33%
Splenectomy
33%
Taiwan
16%
Middle-aged
16%
Peripheral Blood
16%
Interferon-α (IFN-α)
16%
Chemotherapy
16%
Stable Conditions
16%
Treatment Choice
16%
Major Surgery
16%
Adenosine
16%
Older Men
16%
Platelet Count
16%
Physical Checkup
16%
After Surgery
16%
No-report
16%
Complete Remission
16%
Continuous Intravenous Infusion
16%
Sporadic Cases
16%
Pancytopenia
16%
Bone Marrow Biopsy
16%
Neoplastic Cells
16%
Pentostatin
16%
Bicytopenia
16%
Bone Marrow Examination
16%
B-cell Lymphoproliferative Disorder
16%
White Cell Count
16%
Cytopenia
16%
Peripheral Blood Smear
16%
Medicine and Dentistry
Cladribine
100%
Hairy Cell Leukemia
100%
Purine
50%
Disease
33%
Acid Phosphatase Tartrate Resistant Isoenzyme
33%
Splenectomy
33%
Splenomegaly
33%
Leukocyte
16%
Middle Age
16%
Intravenous Drug Administration
16%
B Cell
16%
Interferon
16%
Adenosine
16%
Blood Smear
16%
Major Surgery
16%
Platelet
16%
Lymphoproliferative Disease
16%
Pancytopenia
16%
Bone Marrow Biopsy
16%
Cytopenia
16%
Pentostatin
16%
Bone Marrow Examination
16%
Chemotherapy
16%